4 results match your criteria: "Tangdu Hospital Fourth Military Medical University Xi'an[Affiliation]"
The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trial.
Am J Cancer Res
October 2024
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin 300020, China.
Article Synopsis
- - Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the best curative option for patients with refractory or relapsed acute myeloid leukemia (AML), but long-term survival rates are still not ideal; researchers are working to improve conditioning regimens like the new MCBC (Melphalan, Cladribine, Busulfan, Cyclophosphamide).
- - In a study involving 56 patients treated from July 2020 to January 2022, the 2-year overall survival rate was 60.7% and relapse-free survival rate was 57.1%, with a median follow-up of about 2.3 years.
- - Key findings highlighted that patients
Tumor-associated macrophages (TAMs) greatly contribute to immune checkpoint inhibitor (ICI) resistance of cancer. However, its underlying mechanisms and whether TAMs can be promising targets to overcome ICI resistance remain to be unveiled. Through integrative analysis of immune multiomics data and single-cell RNA-seq data (iMOS) in lung adenocarcinoma (LUAD), lymphotoxin β receptor () is identified as a potential immune checkpoint of TAMs, whose high expression, duplication, and low methylation are correlated with unfavorable prognosis.
View Article and Find Full Text PDFThe use of high-volume 6% hydroxyethyl starch 130/0.4 in massive obstetric hemorrhage.
Int J Obstet Anesth
November 2013
Department of Anesthesiology, Tangdu Hospital Fourth Military Medical University Xi'an, Shaanxi Province, China.
Objective: To study the complete genome sequence of the Chinese Hantaan virus vaccine strain 84FLi and learn about its molecular characters.
Methods: The virus strain 84FLi was isolated from the liver of a fetus aborted by pregnant women with hemorrhagic fever with renal syndrome. The cDNAs of L M and S segments were amplified fragment by fragment using RT-PCR.